4886 Stock Overview
Through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
ASKA Pharmaceutical Holdings Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥2,481.00 |
| 52 Week High | JP¥2,720.00 |
| 52 Week Low | JP¥1,396.00 |
| Beta | 0.55 |
| 11 Month Change | 5.17% |
| 3 Month Change | 14.86% |
| 1 Year Change | 72.17% |
| 33 Year Change | 152.65% |
| 5 Year Change | 87.10% |
| Change since IPO | 18.14% |
Recent News & Updates
Shareholder Returns
| 4886 | JP Pharmaceuticals | JP Market | |
|---|---|---|---|
| 7D | 0.2% | 4.7% | 2.9% |
| 1Y | 72.2% | 7.5% | 20.0% |
Return vs Industry: 4886 exceeded the JP Pharmaceuticals industry which returned 7.5% over the past year.
Return vs Market: 4886 exceeded the JP Market which returned 20% over the past year.
Price Volatility
| 4886 volatility | |
|---|---|
| 4886 Average Weekly Movement | 7.2% |
| Pharmaceuticals Industry Average Movement | 3.8% |
| Market Average Movement | 3.8% |
| 10% most volatile stocks in JP Market | 7.3% |
| 10% least volatile stocks in JP Market | 2.0% |
Stable Share Price: 4886 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4886's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of JP stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1920 | 747 | Takashi Yamaguchi | www.aska-pharma-hd.co.jp |
ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and researches, manufactures, sells, imports, and exports veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also involved in the clinical examination and biological testing activities; and offers medical devices.
ASKA Pharmaceutical Holdings Co.,Ltd. Fundamentals Summary
| 4886 fundamental statistics | |
|---|---|
| Market cap | JP¥70.28b |
| Earnings (TTM) | JP¥7.55b |
| Revenue (TTM) | JP¥62.84b |
9.3x
P/E Ratio1.1x
P/S RatioIs 4886 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4886 income statement (TTM) | |
|---|---|
| Revenue | JP¥62.84b |
| Cost of Revenue | JP¥32.18b |
| Gross Profit | JP¥30.67b |
| Other Expenses | JP¥23.12b |
| Earnings | JP¥7.55b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 266.33 |
| Gross Margin | 48.80% |
| Net Profit Margin | 12.01% |
| Debt/Equity Ratio | 15.3% |
How did 4886 perform over the long term?
See historical performance and comparison